Natale Fabio, Boscarino Giovanni, Liuzzi Giuseppina, Bonci Fabrizia, Albanese Giuseppe Maria, Cellitti Raffaella, Giancotti Antonella, Franco Francesco, Caravale Barbara, Turchetta Rosaria, Turriziani Ombretta, Conti Maria Giulia, Terrin Gianluca
Department of Maternal and Child Health, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.
National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), 00149 Rome, Italy.
J Pers Med. 2025 Apr 24;15(5):165. doi: 10.3390/jpm15050165.
Asymptomatic congenital cytomegalovirus (acCMV) infections represent 85-90% of all congenital CMV infection. The incidence of late-onset sequelae in these cases significantly contribute to the burden of CMV disease. The timing of maternal infection (TMI) has been identified as the main predictor of late-onset sequelae in acCMV infants, and follow-up programs in Europe are currently calibrated according to the TMI. Our aim was to evaluate neonatal viremia as a possible predictor of the TMI in acCMV infections. Plasma viral loads (PVLs) were assessed in the first month of life in a population of acCMV-infected newborns delivered by women who suffer a primary CMV infection during pregnancy. TMI was assigned to a trimester of pregnancy according to the maternal serological screening. PVLs were evaluated in relation to the TMI and gestational age (GA) at birth. One hundred and ten newborns were, respectively, assigned to preconceptional (6.4%), 1st (27.3%), 2nd (38.2%), and 3rd (28.2%) trimester infections. Median neonatal PVLs values were significantly different between groups ( < 0.001). First-trimester infections exhibited significantly higher PVLs when compared with third-trimester ones ( < 0.001). Overall, PVLs showed an inverse correlation with GA at birth ( = 0.003). Median neonatal PVLs are significantly higher in 1st trimester infections if compared with 3rd trimester ones, but a wide overlap between PVL values prevent their possible use as a predictor of the TMI. In our population, a significant inverse relationship, mainly dependent on 1st and 2nd trimester infections, is demonstrated between PVLs and GA. Overall, fetal viremia is already decreasing weeks before the term of pregnancy.
无症状先天性巨细胞病毒(acCMV)感染占所有先天性巨细胞病毒感染的85%-90%。这些病例中迟发性后遗症的发生率显著增加了巨细胞病毒疾病的负担。母体感染时间(TMI)已被确定为acCMV感染婴儿迟发性后遗症的主要预测指标,欧洲目前的随访计划是根据TMI进行校准的。我们的目的是评估新生儿病毒血症作为acCMV感染中TMI的可能预测指标。对孕期发生原发性巨细胞病毒感染的女性所分娩的acCMV感染新生儿群体,在其出生后第一个月评估血浆病毒载量(PVL)。根据母体血清学筛查将TMI分配到妊娠的一个 trimester。评估PVL与TMI和出生时的胎龄(GA)的关系。110名新生儿分别被分配到孕前(6.4%)、第一(27.3%)、第二(38.2%)和第三(28.2%) trimester感染。各组之间的新生儿PVL中位数有显著差异(<0.001)。与第三trimester感染相比,第一trimester感染的PVL显著更高(<0.001)。总体而言,PVL与出生时的GA呈负相关(=0.003)。与第三trimester感染相比,第一trimester感染的新生儿PVL中位数显著更高,但PVL值之间有很大重叠,妨碍了它们作为TMI预测指标的可能用途。在我们的研究群体中,PVL与GA之间存在显著的负相关关系,主要取决于第一和第二trimester感染。总体而言,胎儿病毒血症在妊娠足月前几周就已经在下降。 (注:原文中trimester翻译为“孕期”,这里保留英文以便更准确理解原文语境)